Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
13.47
+0.60 (4.66%)
Sep 22, 2026, 4:00 PM EDT - Market closed

Replimune Group Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BMO Capital
BMO Capital
Buy
Maintains
$20
BuyMaintains$20+48.48%Sep 11, 2026
Unknown Analyst
Kempen & Co
No rating
Kempen & Co
Buy
Initiates
$19
BuyInitiates$19+41.05%Sep 11, 2026
J.P. Morgan
J.P. Morgan
Buy
Reiterates
$20$21
BuyReiterates$20$21+55.90%Aug 26, 2026
Jefferies
Jefferies
Buy
Maintains
$24
BuyMaintains$24+78.17%Aug 17, 2026
Wedbush
Wedbush
Buy
Reiterates
$19
BuyReiterates$19+41.05%Aug 17, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$14
BuyMaintains$14+3.93%Aug 7, 2026
Leerink Partners
Leerink Partners
Buy
Upgrades
$11$17
BuyUpgrades$11$17+26.21%Aug 4, 2026
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Upgrades
n/a
BuyUpgradesn/an/aJul 31, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.